Ryan Specialty Holdings, Inc. (NYSE:RYAN) Receives $70.33 Average Price Target from Analysts

Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) have earned a consensus recommendation of “Hold” from the eleven brokerages that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $70.33.

A number of analysts have issued reports on the stock. UBS Group lifted their target price on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research note on Tuesday, August 13th. Barclays initiated coverage on shares of Ryan Specialty in a research report on Wednesday, September 4th. They set an “overweight” rating and a $76.00 target price on the stock. The Goldman Sachs Group upped their price target on Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 9th. Citigroup raised their price objective on Ryan Specialty from $56.00 to $62.00 and gave the company a “neutral” rating in a research note on Tuesday, July 23rd. Finally, JPMorgan Chase & Co. upped their target price on Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research report on Friday, August 2nd.

Insider Activity at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 5,375 shares of the firm’s stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $64.73, for a total value of $347,923.75. Following the completion of the transaction, the director now directly owns 2,685 shares of the company’s stock, valued at $173,800.05. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the company’s stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total value of $1,709,866.94. Following the sale, the executive vice president now directly owns 24,845 shares in the company, valued at approximately $1,619,397.10. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Nicholas Dominic Cortezi sold 5,375 shares of the stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $64.73, for a total value of $347,923.75. Following the completion of the transaction, the director now directly owns 2,685 shares of the company’s stock, valued at approximately $173,800.05. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 2,107,136 shares of company stock worth $131,860,032. Company insiders own 11.10% of the company’s stock.

Institutional Trading of Ryan Specialty

Large investors have recently bought and sold shares of the stock. Hollencrest Capital Management bought a new stake in Ryan Specialty during the third quarter worth about $25,000. Assetmark Inc. acquired a new stake in Ryan Specialty during the 3rd quarter valued at $34,000. GAMMA Investing LLC raised its position in Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after purchasing an additional 297 shares during the last quarter. Crewe Advisors LLC acquired a new position in Ryan Specialty in the second quarter worth $39,000. Finally, Signaturefd LLC grew its holdings in shares of Ryan Specialty by 12.3% during the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after purchasing an additional 148 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors.

Ryan Specialty Price Performance

NYSE RYAN opened at $68.92 on Monday. The company has a 50 day simple moving average of $67.21 and a 200-day simple moving average of $60.81. Ryan Specialty has a 52-week low of $41.49 and a 52-week high of $73.10. The firm has a market capitalization of $18.02 billion, a price-to-earnings ratio of 89.61, a price-to-earnings-growth ratio of 1.52 and a beta of 0.62. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The company had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. During the same quarter last year, the business posted $0.32 EPS. The company’s revenue for the quarter was up 20.5% on a year-over-year basis. Equities research analysts predict that Ryan Specialty will post 1.81 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be given a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date is Tuesday, November 12th. Ryan Specialty’s dividend payout ratio is currently 57.14%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.